Healthy Adults
Conditions
Interventions
Single intake of bitter melon and foods containing corosolic acid
Single intake of placebo foods containing corosolic acid
Sponsors
Lifix Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Male and female subjects aged 20 to 64 years (2) Normal to slightly elevated fasting blood glucose level (125 mg/dL or less) at baseline (3) Subjects who give written voluntary consent to participate in the study
Exclusion criteria
Exclusion criteria: (1) Those who have been diagnosed with diabetes and are currently undergoing treatment (2) Those who are currently taking medication for diabetes or high blood pressure (3) Those who are currently taking the test food or health food (4) Those who regularly take supplements related to cholesterol, blood pressure, blood lipids, or blood sugar levels (5) Those with serious diseases or mental disorders of the following systems: sugar metabolism, lipid metabolism, liver function, kidney function, heart, circulatory system, respiratory system, endocrine system, immune system, or nervous system. Those with a history of such diseases or disorders (6) Those who have been found to have abnormal clinical test values and are judged to have problems participating in the study (7) Those with diseases that are currently being treated or who have a history of serious diseases that required medication treatment (8) Those who may develop allergies in relation to the study (9) Those who are judged to be unsuitable as subjects based on the results of the lifestyle questionnaire (10) Those who are participating in other clinical research at the start of this study (11) Those who are pregnant or plan to become pregnant or breastfeed during the study period (12) Those who are judged to be unsuitable for participation in the study by the principal investigator (or the person in charge of conducting the study)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in postprandial blood glucose levels | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in postprandial insulin | — |
Countries
Japan
Contacts
Public ContactShigefumi Nibun
EAS inc. Clinical Trial Session
Outcome results
None listed